Student
University of Southern California
Dr. Lequina Myles, DRSc, MS, MBA, RAC, PMP, PMI-ACP, has over ten years of experience within the pharmaceutical and biotechnology industries. Lequina currently works as a Senior Director of Quality Assurance and Regulatory Affairs Phenomenex (a Danaher Company), responsible for global oversight for regulatory strategy and quality compliance. Her previous role was Regional Quality Director providing quality oversight for international and domestic life science, medical product, and clinical trial supply chain management and distribution.
Lequina started her career in the Quality Control Biochemistry Laboratories and moved up through the ranks managing and supporting global projects, which increased organizational efficiency, productivity, and improved client retention and strategic partnerships. Also, Lequina has provided expertise in project management, continuous improvement, and training and development to various organizations.
Lequina holds a B.S. in Biochemistry from the University of California, Los Angeles (UCLA) and a Master of Business Administration (MBA) with an emphasis in Project Management from Mount Saint Mary's University. Lequina also obtained a Master of Regulatory Science and Doctor of Regulatory Science (DRSc) from the University of Southern California. Lequina’s dissertation was focused on implementation strategies for clinical supply chain management of time-sensitive and temperature-sensitive cell and gene therapies. Lequina is a certified Project Management Professional (PMP) and holds a Regulatory Affairs Certification (RAC) in both drugs and devices.
In addition to industry experience, Lequina is an Adjunct Faculty at Mount Saint Mary's University and San Francisco State University teaching project management, quality and regulatory affairs, pharmaceutical supply chain, and clinical trials management.
Lequina is passionate about learning and solving innovative and complex problems. Lequina’s research interests are innovative therapies such as cell and gene therapies and developing clinical and commercial strategies to improve patient access and address unmet medical needs. She also enjoys traveling, mentoring others, and teaching.
Disclosure information not submitted.
Monday, September 12, 2022
11:45 AM – 12:15 PM MST